Formulary
No Formulary Selected

close

 

Select a medication above to begin.

common garlic

garlic (Allium sativum)

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Entire Monograph

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • allergic rhinitis [Insufficient Evidence]
  • alopecia areata [Insufficient Evidence]
  • angina, unstable [Insufficient Evidence]
  • asthma [Insufficient Evidence]
  • atherosclerosis [Possibly Effective]
  • athletic performance [Insufficient Evidence]
  • bladder CA [Insufficient Evidence]
  • BPH [Insufficient Evidence]
  • bronchitis [Insufficient Evidence]
  • cancer prevention, breast [Insufficient Evidence]
  • cancer prevention, colorectal [Insufficient Evidence]
  • cancer prevention, esophageal [Insufficient Evidence]
  • cancer prevention, gastric [Possibly Ineffective]
  • cancer prevention, lung [Insufficient Evidence]
  • candidiasis, oropharyngeal [Insufficient Evidence]
  • candidiasis, vulvovaginal [Insufficient Evidence]
  • cardiovascular disease [Insufficient Evidence]
  • chronic fatigue syndrome [Insufficient Evidence]
  • common cold [Insufficient Evidence]
  • corns [Insufficient Evidence]
  • coronary heart disease [Insufficient Evidence]
  • COVID-19 [Insufficient Evidence]
  • cystic fibrosis [Insufficient Evidence]
  • dental hypersensitivity [Insufficient Evidence]
  • denture stomatitis [Insufficient Evidence]
  • diabetes mellitus [Possibly Effective]
  • diabetic retinopathy [Insufficient Evidence]
  • diarrhea [Insufficient Evidence]
  • dysmenorrhea [Insufficient Evidence]
  • endometriosis [Possibly Effective]
  • erectile dysfunction [Insufficient Evidence]
  • exercise-induced muscle soreness [Insufficient Evidence]
  • familial hypercholesterolemia [Insufficient Evidence]
  • fatigue [Insufficient Evidence]
  • fibrocystic breast disease [Insufficient Evidence]
  • gastritis [Insufficient Evidence]
  • gout [Insufficient Evidence]
  • hepatitis [Insufficient Evidence]
  • hepatopulmonary syndrome [Insufficient Evidence]
  • H. pylori infection [Possibly Ineffective]
  • HTN [Possibly Effective]
  • hyperlipidemia [Possibly Effective]
  • influenza [Insufficient Evidence]
  • lead toxicity [Insufficient Evidence]
  • metabolic dysfunction-associated steatotic liver disease [Possibly Effective]
  • metabolic syndrome [Insufficient Evidence]
  • mosquito repellent [Insufficient Evidence]
  • multiple myeloma [Insufficient Evidence]
  • muscle strength [Insufficient Evidence]
  • obesity [Insufficient Evidence]
  • onychomycosis [Insufficient Evidence]
  • osteoarthritis [Insufficient Evidence]
  • otitis media [Insufficient Evidence]
  • periodontitis [Possibly Effective]
  • peripheral arterial disease [Insufficient Evidence]
  • polycystic ovary syndrome [Insufficient Evidence]
  • pre-eclampsia [Insufficient Evidence]
  • premenstrual syndrome [Insufficient Evidence]
  • prostate CA [Insufficient Evidence]
  • rheumatoid arthritis [Insufficient Evidence]
  • scleroderma [Insufficient Evidence]
  • stress [Insufficient Evidence]
  • tick repellent [Insufficient Evidence]
  • tinea capitis [Insufficient Evidence]
  • tinea corporis [Insufficient Evidence]
  • tinea cruris [Insufficient Evidence]
  • tinea pedis [Insufficient Evidence]
  • trichomoniasis [Insufficient Evidence]
  • tuberculosis [Insufficient Evidence]
  • UTI [Insufficient Evidence]
  • warts [Insufficient Evidence]
  • wound healing [Insufficient Evidence]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Special Note

[formulation clarification]
Info: active constituents may include allicin, ajoene, other organosulfur compounds

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

alopecia areata

[Insufficient Evidence]
Dose: apply 5% gel topically qid; Info: used with topical corticosteroid

angina, unstable

[Insufficient Evidence]
Dose: 60 mg IV qd

atherosclerosis

[Possibly Effective]
Dose: 900 mg/day garlic powder PO divided qd-tid; Alt: 300 mg garlic powder PO x1; 150 mg garlic powder PO bid; 250 mg aged garlic extract PO qd; 1200 mg aged garlic extract PO qd-bid

athletic performance

[Insufficient Evidence]
Dose: 900 mg PO x1 before exercise

BPH

[Insufficient Evidence]
Dose: 1 mg/kg/dose garlic extract PO qd

cancer prevention, colorectal

[Insufficient Evidence]
Dose: 2.4 mL aged garlic extract PO qd

candidiasis, oropharyngeal

[Insufficient Evidence]
Dose: apply paste topically qid

candidiasis, vulvovaginal

[Insufficient Evidence]
Dose: apply cream PV qhs

cardiovascular disease

[Insufficient Evidence]
Dose: 250 mg aged black garlic extract PO qd

common cold prevention

[Insufficient Evidence]
Dose: 180 mg allicin PO qd; Alt: 14 mg garlic powder PO qd

corns

[Insufficient Evidence]
Dose: apply liquid extract topically bid

coronary heart disease

[Insufficient Evidence]
Dose: 800-2000 mg PO qd

COVID-19

[Insufficient Evidence]
Dose: 50 mg garlic oil PO bid x10 days; Info: used with standard tx

denture stomatitis

[Insufficient Evidence]
Dose: 40 mg/mL mouthwash swish/spit tid

diabetes mellitus

[Possibly Effective]
Dose: 600-1500 mg/day garlic powder PO divided bid-tid; Alt: 8.2 mg garlic oil PO qd; 1000 mg aged garlic extract PO qd; Info: used with or without metformin

diabetic retinopathy

[Insufficient Evidence]
Dose: 1 g garlic powder PO qd

endometriosis

[Possibly Effective]
Dose: 400 mg garlic powder PO qd; Info: used with standard tx

erectile dysfunction

[Insufficient Evidence]
Dose: 5 g/150 mL garlic juice PO bid; Info: used with tadalafil

exercise-induced muscle soreness

[Insufficient Evidence]
Dose: 80 mg allicin PO qd

fibrocystic breast disease

[Insufficient Evidence]
Dose: 150 mg garlic powder PO bid

gastritis

[Insufficient Evidence]
Dose: 150 mg garlic powder PO bid

hepatitis

[Insufficient Evidence]
Dose: 150-300 mg garlic oil PO qd

hepatopulmonary syndrome

[Insufficient Evidence]
Dose: 1-2 g/m^2/day garlic oil PO divided bid

HTN

[Possibly Effective]
Dose: 300-1500 mg/day garlic powder PO divided qd-tid; Alt: 2400 mg garlic powder PO x1; 500 mg garlic oil PO qd; 960-7200 mg/day aged garlic extract PO divided qd-tid

hyperlipidemia

[Possibly Effective]
Dose: 600-7200 mg/day aged garlic extract or garlic powder PO divided bid-tid; Alt: 300 mg garlic powder PO bid; 1200 mg PO qd; 250 mg aged garlic extract PO qd; 500 mg garlic oil PO qd

influenza

[Insufficient Evidence]
Dose: 14 mg garlic powder PO qd

lead toxicity

[Insufficient Evidence]
Dose: 400 mg garlic powder PO tid

metabolic dysfunction-associated steatotic liver disease

[Possibly Effective]
Dose: 800-1600 mg garlic powder PO qd; Alt: 400-800 mg garlic powder PO bid

metabolic syndrome

[Insufficient Evidence]
Dose: 5000-20,000 mg raw garlic PO qd; Alt: 240-6000 mg aged garlic extract PO qd; 188-6000 mg garlic powder PO qd; 2.34 mg ajoene PO qd

obesity

[Insufficient Evidence]
Dose: 1600 mg garlic powder PO qd

osteoarthritis

[Insufficient Evidence]
Dose: 500 mg PO bid

periodontitis

[Possibly Effective]
Dose: 1200 mg aged garlic extract PO bid

peripheral arterial disease

[Insufficient Evidence]
Dose: 400 mg PO bid

polycystic ovary syndrome

[Insufficient Evidence]
Dose: 800 mg PO qd; Alt: 500 mg PO bid

premenstrual syndrome

[Insufficient Evidence]
Dose: 400 mg dried garlic powder PO qd

prostate CA

[Insufficient Evidence]
Dose: 1 mg/kg/dose garlic extract PO qd

rheumatoid arthritis

[Insufficient Evidence]
Dose: 500 mg dried garlic PO bid

tick repellent

[Insufficient Evidence]
Dose: 1200 mg PO qd

tinea corporis

[Insufficient Evidence]
Dose: apply 0.6% ajoene gel topically bid

tinea cruris

[Insufficient Evidence]
Dose: apply 0.6% ajoene gel topically bid

tinea pedis

[Insufficient Evidence]
Dose: apply 0.4-1% ajoene gel topically bid

warts

[Insufficient Evidence]
Dose: apply liquid extract topically bid

wound healing

[Insufficient Evidence]
Dose: apply 30% ointment topically bid

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form